Will Infant Hepatitis B Immunization Protect Adults?

David W Scheifele1

  • 1From the Vaccine Evaluation Center, BC Children's Hospital Research Institute, Vancouver, Canada.

Insights

Infant hepatitis B (HBV) vaccination significantly lowers chronic infections in children. Booster shots are not currently recommended for teens or young adults, despite waning antibody levels.

Area of Science:

  • Immunology
  • Public Health
  • Virology

Background:

  • Infant hepatitis B virus (HBV) immunization programs are reducing childhood chronic infections.
  • Key goals include increasing birth dose coverage and preventing perinatal HBV transmission.

Purpose of the Study:

  • To evaluate the long-term effectiveness of infant HBV immunization.
  • To determine the need for booster vaccinations in adolescents and young adults.

Main Methods:

  • Analysis of follow-up studies on individuals immunized in infancy.
  • Assessment of antibody levels and response to challenge vaccination in teenage years.

Main Results:

  • Most immunized infants lose circulating anti-HBs antibodies by adolescence.
  • Some individuals show a reduced response to booster HBV vaccination.
  • Breakthrough HBV infections are rare and rarely lead to chronic infection.

Conclusions:

  • Current evidence does not support routine booster immunizations for healthy adolescents or young adults.
  • Longer-term studies into adulthood are necessary to fully assess protection duration.

Related Concept Videos

What is the Immune System?01:38

What is the Immune System?

Overview
127.1K
Zones of Protection01:16

Zones of Protection

In power systems, the entire setup is divided into protective zones to isolate faults and protect the rest of the network. These zones include generators, transformers, buses, transmission lines, distribution lines, and motors. Each zone can be visualized as a separate room in a house, with each room protected by its own circuit breaker.
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
779
Protection of Alcohols02:31

Protection of Alcohols

This lesson delves into the concept of protection and deprotection of a functional group fundamental to synthetic organic chemistry. These phenomena are explained in the context of aliphatic and aromatic alcohols.
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
8.0K
Protecting Self-Esteem01:27

Protecting Self-Esteem

Self-esteem, a central component of psychological well-being, is actively maintained through various cognitive and behavioral strategies. Individuals employ specific mechanisms to preserve a positive self-concept and mitigate threats to their self-worth, particularly in contexts involving social evaluation or personal feedback. Four primary techniques are commonly used to sustain self-esteem.Manipulating AppraisalsOne prominent strategy involves manipulating appraisals from others. Individuals...
204
Radial System Protection01:23

Radial System Protection

Radial systems employ time-delay overcurrent relays to reduce load interruptions. When a fault occurs, the nearest breaker opens first, while upstream breakers remain closed due to longer delay settings. This approach ensures minimal disruption to the rest of the system.
In a radial system with a fault downstream of the third breaker, ideally, only the third breaker will open, isolating the fault and interrupting the load connected beyond it. The second breaker has a longer delay setting,...
431
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261